150 related articles for article (PubMed ID: 12090563)
21. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
22. Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study.
Liang Y; Leng RX; Pan HF; Ye DQ
Med Sci Monit; 2017 May; 23():2543-2549. PubMed ID: 28548078
[TBL] [Abstract][Full Text] [Related]
23. Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.
Sebastiani GD; Prevete I; Piga M; Iuliano A; Bettio S; Bortoluzzi A; Coladonato L; Tani C; Spinelli FR; Fineschi I; Mathieu A
Lupus; 2015 Oct; 24(12):1276-82. PubMed ID: 25979916
[TBL] [Abstract][Full Text] [Related]
24. HLA antigens in systemic lupus erythematosus: relationship to disease severity, age at onset, and sex.
Bell DA; Rigby R; Stiller CR; Clark WF; Harth M; Ebers G
J Rheumatol; 1984 Aug; 11(4):475-9. PubMed ID: 6332909
[TBL] [Abstract][Full Text] [Related]
25. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
[TBL] [Abstract][Full Text] [Related]
26. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
[TBL] [Abstract][Full Text] [Related]
27. Human leukocyte antigen and autoantibodies association with juvenile systemic lupus erythematosus.
El Sherbini HM; El Garf AK; El Din Mahmoud SS
Egypt J Immunol; 2009; 16(2):107-14. PubMed ID: 22059358
[TBL] [Abstract][Full Text] [Related]
28. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
29. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
Hoffman IE; Peene I; Meheus L; Huizinga TW; Cebecauer L; Isenberg D; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
Ann Rheum Dis; 2004 Sep; 63(9):1155-8. PubMed ID: 15308527
[TBL] [Abstract][Full Text] [Related]
30. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
31. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease.
Harley JB; Sestak AL; Willis LG; Fu SM; Hansen JA; Reichlin M
Arthritis Rheum; 1989 Jul; 32(7):826-36. PubMed ID: 2787639
[TBL] [Abstract][Full Text] [Related]
32. Clinical and histopathological features of myositis in systemic lupus erythematosus.
Tiniakou E; Goldman D; Corse A; Mammen A; Petri MA
Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35351810
[TBL] [Abstract][Full Text] [Related]
33. The progressive systemic sclerosis/systemic lupus overlap: an unusual clinical progression.
Asherson RA; Angus H; Mathews JA; Meyers O; Hughes GR
Ann Rheum Dis; 1991 May; 50(5):323-7. PubMed ID: 2042989
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases.
Garton MJ; Isenberg DA
Br J Rheumatol; 1997 Oct; 36(10):1067-74. PubMed ID: 9374923
[TBL] [Abstract][Full Text] [Related]
35. Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies.
Arnett FC; Bias WB; McLean RH; Engel M; Duvic M; Goldstein R; Freni-Titulaer L; McKinley TW; Hochberg MC
J Rheumatol; 1990 Aug; 17(8):1029-35. PubMed ID: 1976808
[TBL] [Abstract][Full Text] [Related]
36. Clinical, serologic, and immunogenetic characterization (HLA-DRB1) of late-onset lupus erythematosus in a Colombian population.
Peñaranda-Parada E; Quintana G; Yunis JJ; Mantilla R; Rojas W; Panqueva U; Caminos JE; Garces MF; Sanchez E; Rondón-Herrera F; de Jesús Iglesias-Gamarra A
Lupus; 2015 Oct; 24(12):1293-9. PubMed ID: 26022697
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
Farber SJ; Bole GG
Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.
Choi JH; Park DJ; Kang JH; Yim YR; Lee KE; Lee JW; Wen L; Kim TJ; Park YW; Lee JK; Lee SS
Lupus; 2015 Oct; 24(12):1342-9. PubMed ID: 26085595
[TBL] [Abstract][Full Text] [Related]
39. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
Al Attia HM
Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
[TBL] [Abstract][Full Text] [Related]
40. Myositis in systemic lupus erythematosus.
Cotton T; Niaki OZ; Zheng B; Pineau CA; Fritzler M; Vinet E; Clarke AE; Bernatsky S
Lupus; 2021 Apr; 30(4):615-619. PubMed ID: 33461416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
